CD79A and breast carcinoma: More informative data were noted about the highly significant decrease of the SNA/IgA index, which demonstrated an about 77% accuracy of diagnostics also at the very early stages of breast cancer (0+1) (Figure 7(b)) when the sensitivity was 62.5% even at 90% specificity (Table 2).